Skip to main content
. 2021 Sep 20;59(10):e00811-21. doi: 10.1128/JCM.00811-21

FIG 4.

FIG 4

COVID-19 patients with indeterminate IFN-γ controls have similar critical disease scores and survival outcomes. (A) Hospitalized COVID-19 patients with indeterminate IFN-γ controls have similar COVID-19 GRAM severity risk scores compared to patients with acceptable IFN-γ controls. (B) COVID-19 patients with indeterminate IFN-γ controls have similar survival outcomes during infection compared to patients with acceptable IFN-γ controls. Nonparametric scores between groups were performed using Mann-Whitney U test, and the survival curve comparison for COVID-19 patients between the IFN-γ groups was performed using the Gehan-Breslow-Wilcoxon test. The difference between the means was considered significant if the P value was less than 0.05.